Search

Author/Creator List, Alan F.

11. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes. Issue 11 (27th February 2014)

Authors:
Steensma, David P.; Komrokji, Rami S.; Stone, Richard M.; List, Alan F.; Garcia‐Manero, Guillermo; Huber, John M.; Dennison, Betsy; Sekeres, Mikkael A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1670
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes. Issue 11 (27th February 2014)

Authors:
Steensma, David P.; Komrokji, Rami S.; Stone, Richard M.; List, Alan F.; Garcia‐Manero, Guillermo; Huber, John M.; Dennison, Betsy; Sekeres, Mikkael A.
Journal:
Cancer
Issue:
Volume 120:Issue 11(2014)
Page Start:
1670
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Driver mutation‐specific clinical and genomic correlates differ between primary and secondary myelofibrosis. Issue 12 (10th September 2019)

Authors:
Kuykendall, Andrew T.; Talati, Chetasi; Padron, Eric; Sweet, Kendra; Lancet, Jeffrey E.; List, Alan F.; Sallman, David; Komrokji, Rami S.
Journal:
American journal of hematology
Issue:
Volume 94:Issue 12(2019:Dec.)
Page Start:
E314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Issue 14 (10th May 2021)

Authors:
Sallman, David A.; DeZern, Amy E.; Garcia-Manero, Guillermo; Steensma, David P.; Roboz, Gail J.; Sekeres, Mikkael A.; Cluzeau, Thomas; Sweet, Kendra L.; McLemore, Amy; McGraw, Kathy L.; Puskas, John; Zhang, Ling; Yao, Jiqiang; Mo, Qianxing; Nardelli, Lisa; Al Ali, Najla H.; Padron, Eric; Korbel, ...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 14(2021)
Page Start:
1584
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients. Issue 1 (25th November 2018)

Authors:
Kuykendall, Andrew T.; Talati, Chetasi; Padron, Eric; Sweet, Kendra; Sallman, David; List, Alan F.; Lancet, Jeffrey E.; Komrokji, Rami S.
Journal:
American journal of hematology
Issue:
Volume 94:Issue 1(2019:Jan.)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning. (2022)

Authors:
Sallman, David A.; Bejar, Rafael; Montalban-Bravo, Guillermo; Kurtin, Sandra E.; List, Alan F.; Garcia-Manero, Guillermo; Nimer, Stephen D.; O'Connell, Casey L.; Schaar, Dale; Butchko, Janice; Iraca, Tracey; Searle, Stephanie
Journal:
Leukemia research reports
Issue:
Volume 17(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin. Issue 9 (20th March 2021)

Authors:
List, Alan F.; Sun, Zhuoxin; Verma, Amit; Bennett, John M.; Komrokji, Rami S.; McGraw, Kathy; Maciejewski, Jaroslaw; Altman, Jessica K.; Cheema, Puneet S.; Claxton, David F.; Luger, Selina M.; Mattison, Ryan J.; Wassenaar, Timothy R.; Artz, Andrew S.; Schiffer, Charles A.; Litzow, Mark R.; Tallma...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 9(2021)
Page Start:
1001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium. Issue 6 (19th November 2014)

Authors:
Jabbour, Elias J.; Garcia‐Manero, Guillermo; Strati, Paolo; Mishra, Asmita; Al Ali, Najla H.; Padron, Eric; Lancet, Jeffrey; Kadia, Tapan; Daver, Naval; O'Brien, Susan; Steensma, David P.; Sekeres, Mikkael A.; Gore, Steven D.; Dezern, Amy; Roboz, Gail J.; List, Alan F.; Kantarjian, Hagop M.; Komr...
Journal:
Cancer
Issue:
Volume 121:Issue 6(2015)
Page Start:
876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗